Tapewire

Nasdaq · USD

TCMD

TACTILE SYSTEMS TECHNOLOGY INC

Export transactions ↓
Tapewire entity
5451
SEC CIK
0001027838
Parsed reports
468

Last 12 months

Inside the activity.

0 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202601
Feb 202609
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 10, 2026 Filed Aug 12, 2026 20:22 UTC
Dodd Sheri LouiseDirector · Chief Executive Officer
SaleCommon Stock 10,978 $29.44 $323,242.82
Disclosure

SEC source: 0001837111-26-000007 · form4-08122026_080842.xml · nonDerivative · entry 1

Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,907

F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 10,978 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on August 10, 2026 with sale prices ranging from $28.93 to $29.81 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 11, 2026 Filed May 13, 2026 21:01 UTC
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
SaleCommon Stock 4,631 $24.49 $113,403.93
Disclosure

SEC source: 0001968559-26-000007 · form4-05132026_090558.xml · nonDerivative · entry 1

Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,188

F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 4,631 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 11, 2026 with sale prices ranging from $23.89 to $25.42 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 06, 2026 Filed May 8, 2026 21:31 UTC GrantCommon Stock 6,521 $0.00 $0.00
Disclosure

SEC source: 0001904264-26-000002 · form4-05082026_090553.xml · nonDerivative · entry 1

Asbury Valerie L. · CIK 0001904264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,343

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 06, 2026 Filed May 8, 2026 21:31 UTC GrantCommon Stock 6,521 $0.00 $0.00
Disclosure

SEC source: 0001596078-26-000002 · form4-05082026_090525.xml · nonDerivative · entry 1

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,841

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 06, 2026 Filed May 8, 2026 21:31 UTC GrantCommon Stock 6,521 $0.00 $0.00
Disclosure

SEC source: 0002049487-26-000002 · form4-05082026_090555.xml · nonDerivative · entry 1

King Laura G. · CIK 0002049487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,569

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 06, 2026 Filed May 8, 2026 21:30 UTC GrantCommon Stock 6,521 $0.00 $0.00
Disclosure

SEC source: 0001478345-26-000010 · form4-05082026_090522.xml · nonDerivative · entry 1

Pearson Andrea · CIK 0001478345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,373

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 06, 2026 Filed May 8, 2026 21:29 UTC GrantCommon Stock 6,521 $0.00 $0.00
Disclosure

SEC source: 0001728374-26-000002 · form4-05082026_090541.xml · nonDerivative · entry 1

Shafer David Brent · CIK 0001728374 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,343

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 06, 2026 Filed May 8, 2026 21:29 UTC GrantCommon Stock 6,521 $0.00 $0.00
Disclosure

SEC source: 0001282953-26-000002 · form4-05082026_090506.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,219

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 06, 2026 Filed May 8, 2026 21:28 UTC GrantCommon Stock 6,521 $0.00 $0.00
Disclosure

SEC source: 0001994641-26-000002 · form4-05082026_090535.xml · nonDerivative · entry 1

Washington Boyd Vindell · CIK 0001994641 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,768

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 06, 2026 Filed May 8, 2026 21:28 UTC GrantCommon Stock 6,521 $0.00 $0.00
Disclosure

SEC source: 0001200612-26-000002 · form4-05082026_090504.xml · nonDerivative · entry 1

BURKE WILLIAM W · CIK 0001200612 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,041

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:13 UTC GrantCommon Stock 852 $0.00 $0.00
Disclosure

SEC source: 0001478345-26-000008 · form4-03112026_080348.xml · nonDerivative · entry 1

Pearson Andrea · CIK 0001478345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 852

F1 · shares: Represents restricted stock units that will vest in full on the date of the Company's 2026 annual meeting of stockholders.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:57 UTC
Dodd Sheri LouiseDirector · Chief Executive Officer
SaleCommon Stock 10,993 $28.94 $318,144.02
Disclosure

SEC source: 0001837111-26-000005 · form4-02262026_090218.xml · nonDerivative · entry 1

Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,885

F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 10,993 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:56 UTC
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
SaleCommon Stock 7,701 $28.94 $222,880.03
Disclosure

SEC source: 0001968559-26-000005 · form4-02262026_090201.xml · nonDerivative · entry 1

Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,819

F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 7,701 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:55 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 6,246 $28.94 $180,764.24
Disclosure

SEC source: 0001857721-26-000007 · form4-02262026_090232.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,581

F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 6,246 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 23, 2026 Filed Feb 24, 2026 22:32 UTC
Dodd Sheri LouiseDirector · Chief Executive Officer
SaleCommon Stock 537 $28.69 $15,406.05
Disclosure

SEC source: 0001837111-26-000004 · form4-02242026_100251.xml · nonDerivative · entry 4

Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,878

F3 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F5 · price: Reflects the weighted average price of 537 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 23, 2026 Filed Feb 24, 2026 22:32 UTC
Dodd Sheri LouiseDirector · Chief Executive Officer
SaleCommon Stock 14,703 $28.28 $415,839.07
Disclosure

SEC source: 0001837111-26-000004 · form4-02242026_100251.xml · nonDerivative · entry 3

Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,415

F3 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F4 · price: Reflects the weighted average price of 14,703 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 23, 2026 Filed Feb 24, 2026 22:33 UTC
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
SaleCommon Stock 196 $28.69 $5,623.08
Disclosure

SEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 5

Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,520

F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F6 · price: Reflects the weighted average price of 196 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 23, 2026 Filed Feb 24, 2026 22:33 UTC
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
SaleCommon Stock 5,322 $28.28 $150,520.53
Disclosure

SEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 4

Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,716

F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F5 · price: Reflects the weighted average price of 5,322 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 23, 2026 Filed Feb 24, 2026 22:32 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 160 $28.69 $4,590.29
Disclosure

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 5

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,827

F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F6 · price: Reflects the weighted average price of 160 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 23, 2026 Filed Feb 24, 2026 22:32 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 4,279 $28.28 $121,021.67
Disclosure

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 4

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,987

F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F5 · price: Reflects the weighted average price of 4,279 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 22:32 UTC
Dodd Sheri LouiseDirector · Chief Executive Officer
GrantCommon Stock 28,216 $0.00 $0.00
Disclosure

SEC source: 0001837111-26-000004 · form4-02242026_100251.xml · nonDerivative · entry 2

Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,118

F2 · shares: On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 28,216 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 22:32 UTC
Dodd Sheri LouiseDirector · Chief Executive Officer
GrantCommon Stock 19,751 $0.00 $0.00
Disclosure

SEC source: 0001837111-26-000004 · form4-02242026_100251.xml · nonDerivative · entry 1

Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241,902

F1 · shares: On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 19,751 PSUs. Those earned PSUs vested on February 20, 2026.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 22:33 UTC
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
GrantCommon Stock 15,575 $0.00 $0.00
Disclosure

SEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 3

Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,038

F3 · shares: On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 15,575 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 22:33 UTC
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
GrantCommon Stock 6,765 $0.00 $0.00
Disclosure

SEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 2

Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,463

F2 · shares: On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 6,765 PSUs. Those earned PSUs vested on February 20, 2026.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 22:33 UTC
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
GrantCommon Stock 3,579 $0.00 $0.00
Disclosure

SEC source: 0001968559-26-000004 · form4-02242026_100219.xml · nonDerivative · entry 1

Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,698

F1 · shares: On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 3,579 PSUs. Those earned PSUs vested on February 20, 2026.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 22:32 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
GrantCommon Stock 7,123 $0.00 $0.00
Disclosure

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 3

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,266

F3 · shares: On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 7,123 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 22:32 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
GrantCommon Stock 4,058 $0.00 $0.00
Disclosure

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 2

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,143

F2 · shares: On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 4,058 PSUs. Those earned PSUs vested on February 20, 2026.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 22:32 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
GrantCommon Stock 3,490 $0.00 $0.00
Disclosure

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,085

F1 · shares: On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 3,490 PSUs. Those earned PSUs vested on February 20, 2026.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 21:47 UTC
Dodd Sheri LouiseDirector · Chief Executive Officer
GrantCommon Stock 48,672 $0.00 $0.00
Disclosure

SEC source: 0001837111-26-000002 · form4-02232026_090243.xml · nonDerivative · entry 1

Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,151

F1 · shares: Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 21:47 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
GrantCommon Stock 6,194 $0.00 $0.00
Disclosure

SEC source: 0001857721-26-000004 · form4-02232026_090210.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,595

F1 · shares: Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 21:46 UTC
Birkemeyer Elaine M.CHIEF FINANCIAL OFFICER
GrantCommon Stock 23,008 $0.00 $0.00
Disclosure

SEC source: 0001968559-26-000002 · form4-02232026_090215.xml · nonDerivative · entry 1

Birkemeyer Elaine M. · CIK 0001968559 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,119

F1 · shares: Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:53 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 5,139 $28.85 $148,260.15
Disclosure

SEC source: 0001857721-26-000002 · form4-01062026_090117.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,401

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 9/11/2025.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 22:03 UTC
Dodd Sheri LouiseDirector · Chief Executive Officer
SaleCommon Stock 7,762 $12.36 $95,907.27
Disclosure

SEC source: 0001415889-25-021513 · form4-08122025_100828.xml · nonDerivative · entry 1

Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,479

F1 · shares: These shares were sold to cover taxes associated with the settlement of restricted stock units.

Read SEC document
May 12, 2025 Filed May 14, 2025 21:26 UTC
Birkemeyer Elaine M.Chief Financial Officer
SaleCommon Stock 2,921 $9.94 $29,037.37
Disclosure

SEC source: 0001437749-25-016924 · rdgdoc.xml · nonDerivative · entry 1

Birkemeyer Elaine M. · CIK 0001968559 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 99,111

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 2,921 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 12, 2025 with sale prices ranging from $9.935 to $9.945 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 08, 2025 Filed May 9, 2025 20:28 UTC SaleCommon Stock 3,300 $9.67 $31,911.00
Disclosure

SEC source: 0001437749-25-015802 · rdgdoc.xml · nonDerivative · entry 2

BURKE WILLIAM W · CIK 0001200612 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,520

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 05-28-2024

F3 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:34 UTC
Dodd Sheri LouiseDirector · Chief Executive Officer
SaleCommon Stock 3,149 $9.83 $30,954.67
Disclosure

SEC source: 0001437749-25-016138 · rdgdoc.xml · nonDerivative · entry 1

Dodd Sheri Louise · CIK 0001837111 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,241

F1 · shares: These shares were sold to cover taxes associated with the settlement of restricted stock units.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:28 UTC GrantCommon Stock 16,078 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-015802 · rdgdoc.xml · nonDerivative · entry 1

BURKE WILLIAM W · CIK 0001200612 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,820

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:28 UTC GrantCommon Stock 16,078 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-015801 · rdgdoc.xml · nonDerivative · entry 1

Asbury Valerie L. · CIK 0001904264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,822

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:27 UTC GrantCommon Stock 16,078 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-015798 · rdgdoc.xml · nonDerivative · entry 1

King Laura G. · CIK 0002049487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,048

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:27 UTC GrantCommon Stock 16,078 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-015800 · rdgdoc.xml · nonDerivative · entry 1

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,320

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:26 UTC GrantCommon Stock 16,078 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-015796 · rdgdoc.xml · nonDerivative · entry 1

Shafer David Brent · CIK 0001728374 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,822

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:26 UTC GrantCommon Stock 16,078 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-015795 · rdgdoc.xml · nonDerivative · entry 1

Volkart Carmen B · CIK 0001282953 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,698

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
May 07, 2025 Filed May 9, 2025 20:25 UTC GrantCommon Stock 16,078 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-015794 · rdgdoc.xml · nonDerivative · entry 1

Washington Boyd Vindell · CIK 0001994641 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,247

F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 20:20 UTC GiftCommon Stock 68,162 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-007530 · rdgdoc.xml · nonDerivative · entry 2

REUVERS DANIEL L. · CIK 0001563602 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 68,162

Read SEC document
March 11, 2025 Filed Mar 13, 2025 20:20 UTC GiftCommon Stock 68,162 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-007530 · rdgdoc.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,442

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:29 UTC
Birkemeyer Elaine M.Chief Financial Officer
SaleCommon Stock 2,066 $14.51 $29,979.52
Disclosure

SEC source: 0001437749-25-005486 · rdgdoc.xml · nonDerivative · entry 1

Birkemeyer Elaine M. · CIK 0001968559 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,032

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 2,066 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.50 to $14.52 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:28 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 6,468 $14.40 $93,159.90
Disclosure

SEC source: 0001437749-25-005484 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,540

F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 6,468 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.40 to $14.41 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:27 UTC SaleCommon Stock 28,338 $14.18 $401,849.84
Disclosure

SEC source: 0001437749-25-005481 · rdgdoc.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 214,604

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 28,338 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.09 to $14.49 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 24, 2025 Filed Feb 24, 2025 23:24 UTC SaleCommon Stock 10,938 $14.55 $159,146.81
Disclosure

SEC source: 0001437749-25-004938 · rdgdoc.xml · nonDerivative · entry 2

REUVERS DANIEL L. · CIK 0001563602 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 242,942

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 06-10-2024

F3 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F4 · price: Reflects the weighted average price of 10,938 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $14.50 to $14.61 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 24, 2025 Filed Feb 24, 2025 23:23 UTC
Burns KristieSr. VP Mktg & Clinical Affairs
SaleCommon Stock 4,830 $14.65 $70,752.74
Disclosure

SEC source: 0001437749-25-004936 · rdgdoc.xml · nonDerivative · entry 4

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,008

F5 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F6 · price: Reflects the weighted average price of 4,830 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $14.4301 to $14.82 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.